Life sciences tools company Agilent Technologies (NYSE: A) will be reporting results this Wednesday after the bell. Here’s what investors should know.
Agilent met analysts’ revenue expectations last quarter, reporting revenues of $1.80 billion, up 7% year on year. It was a mixed quarter for the company, with revenue guidance for next quarter beating analysts’ expectations but revenue in line with analysts’ estimates.
Is Agilent a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Agilent’s revenue to grow 8% year on year, improving from the 6% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Agilent has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Agilent’s peers in the research tools & consumables segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Waters Corporation delivered year-on-year revenue growth of 91.5%, beating analysts’ expectations by 5.3%, and Avantor reported flat revenue, topping estimates by 2.7%. Waters Corporation traded up 15.8% following the results while Avantor was also up 3.1%.
Read our full analysis of Waters Corporation’s results here and Avantor’s results here.
There has been positive sentiment among investors in the research tools & consumables segment, with share prices up 2.7% on average over the last month. Agilent is down 1.2% during the same time and is heading into earnings with an average analyst price target of $161.13 (compared to the current share price of $114.96).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
